Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 661

1.

Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.

Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.

AJR Am J Roentgenol. 2007 Oct;189(4):849.

PMID:
17885055
2.

Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.

Sung YS, Kwon HJ, Park BW, Cho G, Lee CK, Cho KS, Kim JK.

AJR Am J Roentgenol. 2011 Nov;197(5):1122-9. doi: 10.2214/AJR.10.6062.

PMID:
22021504
3.

Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.

Kim JK, Hong SS, Choi YJ, Park SH, Ahn H, Kim CS, Cho KS.

J Magn Reson Imaging. 2005 Nov;22(5):639-46.

PMID:
16200542
4.

Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.

Bloch BN, Furman-Haran E, Helbich TH, Lenkinski RE, Degani H, Kratzik C, Susani M, Haitel A, Jaromi S, Ngo L, Rofsky NM.

Radiology. 2007 Oct;245(1):176-85. Epub 2007 Aug 23.

PMID:
17717328
5.

Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.

Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW.

Invest Radiol. 2009 Sep;44(9):577-84. doi: 10.1097/RLI.0b013e3181b4c1fe.

PMID:
19668002
6.

Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.

Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.

Acta Radiol. 2008 Dec;49(10):1207-13. doi: 10.1080/02841850802508959.

PMID:
19031184
7.

Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.

Franiel T, Lüdemann L, Rudolph B, Rehbein H, Staack A, Taupitz M, Prochnow D, Beyersdorff D.

Invest Radiol. 2008 Jul;43(7):481-7. doi: 10.1097/RLI.0b013e31816b2f63.

PMID:
18580330
8.

Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.

Fennessy FM, Fedorov A, Penzkofer T, Kim KW, Hirsch MS, Vangel MG, Masry P, Flood TA, Chang MC, Tempany CM, Mulkern RV, Gupta SN.

Magn Reson Imaging. 2015 Sep;33(7):886-94. doi: 10.1016/j.mri.2015.02.008. Epub 2015 Feb 14.

9.

Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.

Kim JH, Lee JM, Park JH, Kim SC, Joo I, Han JK, Choi BI.

Radiology. 2013 Jan;266(1):185-96. doi: 10.1148/radiol.12120111. Epub 2012 Nov 28.

PMID:
23192779
10.

Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.

Gemeinhardt O, Lüdemann L, Prochnow D, Abramjuk C, Taupitz M, Hamm B, Beyersdorff D.

Rofo. 2005 Jul;177(7):935-9.

PMID:
15973594
11.

MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.

Riches SF, Payne GS, Morgan VA, Sandhu S, Fisher C, Germuska M, Collins DJ, Thompson A, deSouza NM.

AJR Am J Roentgenol. 2009 Dec;193(6):1583-91. doi: 10.2214/AJR.09.2540.

PMID:
19933651
12.

Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.

Engelbrecht MR, Huisman HJ, Laheij RJ, Jager GJ, van Leenders GJ, Hulsbergen-Van De Kaa CA, de la Rosette JJ, Blickman JG, Barentsz JO.

Radiology. 2003 Oct;229(1):248-54. Epub 2003 Aug 27.

PMID:
12944607
13.

Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.

Othman AE, Falkner F, Martirosian P, Schraml C, Schwentner C, Nickel D, Nikolaou K, Notohamiprodjo M.

Invest Radiol. 2016 Feb;51(2):106-12. doi: 10.1097/RLI.0000000000000213.

PMID:
26447494
14.

A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.

Fedorov A, Fluckiger J, Ayers GD, Li X, Gupta SN, Tempany C, Mulkern R, Yankeelov TE, Fennessy FM.

Magn Reson Imaging. 2014 May;32(4):321-9. doi: 10.1016/j.mri.2014.01.004. Epub 2014 Jan 21.

15.

Evaluation of pancreatic cancer by multiple breath-hold dynamic contrast-enhanced magnetic resonance imaging at 3.0T.

Yao X, Zeng M, Wang H, Sun F, Rao S, Ji Y.

Eur J Radiol. 2012 Aug;81(8):e917-22. doi: 10.1016/j.ejrad.2012.05.011. Epub 2012 Jun 12.

PMID:
22695786
16.

Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate.

Hansford BG, Karademir I, Peng Y, Jiang Y, Karczmar G, Thomas S, Yousuf A, Antic T, Eggener S, Oto A.

Acad Radiol. 2014 May;21(5):569-77. doi: 10.1016/j.acra.2014.01.013.

PMID:
24703469
17.

Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.

Oto A, Fan X, Mustafi D, Jansen SA, Karczmar GS, Rubin DT, Kayhan A.

Acad Radiol. 2009 Oct;16(10):1223-30. doi: 10.1016/j.acra.2009.04.010. Epub 2009 Jun 12.

PMID:
19524458
18.

Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.

Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K.

J Magn Reson Imaging. 2010 Mar;31(3):625-31. doi: 10.1002/jmri.22075.

PMID:
20187206
19.

Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.

Braren R, Curcic J, Remmele S, Altomonte J, Ebert O, Rummeny EJ, Steingoetter A.

Invest Radiol. 2011 Oct;46(10):624-31. doi: 10.1097/RLI.0b013e31821e30e7.

PMID:
21577121
20.

Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.

Carlani M, Mancino S, Bonanno E, Finazzi Agrò E, Simonetti G.

Radiol Med. 2008 Aug;113(5):670-88. doi: 10.1007/s11547-008-0271-8. Epub 2008 May 20. English, Italian.

PMID:
18493829

Supplemental Content

Support Center